ddrg/super_eurlex huggingface dataset:
Non-opposition to a notified concentration

(Case M.10058 — Porsche/Transnet/JV)

(Text with EEA relevance)

(2021/C 5/06)

On 21 December 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M10058. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9974 — Groupe Crédit Agricole/Groupe Generali/Europ Assistance France/Viavita)

(Text with EEA relevance)

(2021/C 20/02)

On 8 December 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes.

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9974. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10068 — Brookfield/Mansa/Polenergia)

(Text with EEA relevance)

(2021/C 14/01)

On 5 January 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10068. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10004 - EQT/Zentricity/Cajelo/Recipharm)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 29/04)

1. On 18 January 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — EQT IX Collect EUR SCSp and EQT IX Collect USD SCSp (together ‘EQT IX’), part of the EQT group of private equity funds (‘EQT’, Luxembourg); — Zentricity Holding AB (‘Zentricity’, Sweden); — Cajelo Invest Ltd (‘Cajelo’, Cyprus); and — Recipharm AB (‘Recipharm’, Sweden). EQT, Zentricity and Cajelo acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Recipharm. The concentration is accomplished by way of public bid announced on 14 December 2020.

2. The business activities of the undertakings concerned are: — for EQT: private equity funds that invest in companies across the world, which amongst others control EQT IX, an investment fund investing primarily in Europe, with a focus on Northern Europe; — for Zentricity: investment company focusing on investing in pharmaceutical companies primarily in Sweden, which is controlled by private individual Thomas Eldered, who also controls the pharmaceutical companies Empros Pharma AB, Flerie Creations Ltd. and Flerie Invest AB; — for Cajelo: investment company which is controlled by private individual Lars Backsell, who also controls Glims Marketing Ltd. and Rohirrim AB, a horse breeding company. — for Recipharm: contract development and manufacturing organization, providing drug development and manufacturing services globally to the pharmaceutical industry (e.g. for finished dose pharmaceuticals, active pharmaceutical ingredients and clinical trial materials for customers in the pharmaceutical industry), as well as packaging services and logistics services.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10004 – EQT/Zentricity/Cajelo/Recipharm Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10131 — Partners Group/Warburg Pincus/Ecom Express Private)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 24/16)

1. On 12 January 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Partners Group AG (‘Partners Group’, Switzerland), — Warburg Pincus LLC (‘Warburg Pincus’, United States), — Ecom Express Private Limited (‘Ecom Express Private’, India) controlled by Warburg Pincus. Partners Group and Warburg Pincus acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Ecom Express Private. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Partners Group: global private markets investment management company active in a range of industries, — for Warburg Pincus: global private equity firm with portfolio companies active in various sectors (e.g. consumer, industrial and business services, energy, financial services, healthcare, real estate, and technology), — for Ecom Express Private: provider of third-party logistics services in India.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10131 — Partners Group/Warburg Pincus/Ecom Express Private Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9893 — C&G/Fischer/Craftnote)

(Text with EEA relevance)

(2021/C 34/03)

On 28 July 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in German language and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9893. EUR-Lex is the online access to the European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10091 — TowerBrook Capital Partners/Warburg Pincus/AA)

(Text with EEA relevance)

(2021/C 31/03)

On 22 January 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10091. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10001 — Microsoft/Zenimax)

(Text with EEA relevance)

(2021/C 40/10)

Microsoft acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of ZeniMax. The concentration is accomplished by way of a merger pursuant to which a newly created Microsoft subsidiary (‘Vault’) will be merged with and into ZeniMax.

On 29 January 2021, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 ( 1 )

for ZeniMax: a privately held company. ZeniMax develops and publishes games for PCs, consoles, and mobile devices.

for Microsoft: a global technology company. Microsoft offers a wide range of products and services to customers through the following operating segments: (i) Productivity and Business Processes, (ii) Intelligent Cloud and (iii) More Personal Computing. This Transaction primarity concerns Microsoft’s gaming business, part of the More Personal Computing operating segment. Microsoft develops, publishes and distributes games for personal computers (‘PCs’), video game consoles and mobile devices. Microsoft also offers the Xbox gaming console.

The business activities of the undertakings concerned are:

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10001 — Microsoft/Zenimax

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:
Non-opposition to a notified concentration

(Case M.8851 — BASF/Bayer Divestment Business)

(Text with EEA relevance)

(2021/C 36/02)

On 30 April 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8851. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10079 — SARP/Suez RV Osis)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 54/05)

1. On 9 February 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Société d’Assainissement Rationnel et de Pompage (‘SARP’, France), controlled by Veolia Environnement (France); — Suez RV OSIS (‘OSIS’, France), belonging to the Suez group. SARP acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of OSIS. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for SARP: a service provider active in the maintenance of sanitation networks and installations, as well as industrial cleaning, mainly in France. SARP is controlled by Veolia Environnement, which provides water, waste and energy management services; — OSIS: a service provider active in the maintenance of sanitation networks and installations, as well as industrial cleaning, in France, Belgium and Luxembourg.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2), it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit any observations they may have on the proposed transaction to the Commission. Observations must reach the Commission no later than ten days following the date on which this notification is published. The following reference should always be specified: M.10079 — SARP/Suez RV Osis Observations can be sent to the Commission by e-mail, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussels BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10141 — Sanacorp Pharmahandel/Leopold Fiebig and Gerda Nückel)

(Text with EEA relevance)

(2021/C 47/08)

1. On 1 February 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Leopold Fiebig GmbH & Co. KG (Germany), — Gerda Nückel GmbH (Germany), — Sanacorp Pharmahandel GmbH (Germany), ultimately controlled by astera SA (France) and Sanacorp eG Pharmazeutische Großhandlung (Germany). Sanacorp Pharmahandel GmbH acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Leopold Fiebig GmbH & Co. KG and Gerda Nückel GmbH. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — Sanacorp Pharmahandel GmbH is a full-service wholesaler of pharmaceuticals operating on the German market. — Leopold Fiebig GmbH & Co. KG is a full-service wholesaler of pharmaceuticals based in Rheinstetten, operating in central and southern Germany. — Gerda Nückel GmbH is the general partner of Leopold Fiebig GmbH & Co. KG.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10141 — Sanacorp Pharmahandel/Leopold Fiebig and Gerda Nückel Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10067 — ElringKlinger/Plastic Omnium New Energies/EKPO Fuel)

(Text with EEA relevance)

(2021/C 65/01)

On 18 February 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10067. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9779 — Alstom/Bombardier Transportation)

(Text with EEA relevance)

(2021/C 61/04)

On 31 July 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9779. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9970 — Cordes & Graefe/FACQ)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 71/09)

1. On 18 January 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Cordes & Graefe KG (‘Cordes & Graefe’, Germany); and — The FACQ Group (‘FACQ’, Belgium). FACQ includes: (a) FACQ SA; (b) Immobilière les blés d’or SA; (c) Immobilière Weideveld SA; and (d) Renoma SRL. Cordes & Graefe acquires, within the meaning of Article 3(1)(b) of the Merger Regulation, sole control over FACQ. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Cordes & Graefe: wholesale and retail supply of sanitary, plumbing, ventilation, heating and air conditioning products, electrical equipment, roofing, excavation and industrial technologies, mainly to professional customers; and — for FACQ: retail supply of sanitary, plumbing, ventilation, heating and air conditioning products to professional and non-professional customers.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9970 — Cordes & Graefe/FACQ Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10128 — Stirling Square Capital Partners/TA Associates/Glenigan)

(Text with EEA relevance)

(2021/C 66/04)

On 19 February 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10128. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.